Abbot Laboratories announced Financial Results for the period ended June 30, 2017.
The company’s Net Sales for the period increased by 10 percent in the outgoing year, whereas the Profit after Taxation for the Period decreased by 1 percent.
Gross Profit increased by 5 percent.
Comparison of Key Financials
Unconsolidated Profit and Loss Account – For the Six Months Ended
Key Financials
Jan – June, 2017
Jan – Jun, 2016
% Change
Amounts in PKR ‘000
Net Sales
12,057,546
10,966,427
10%
Domestic
11,377,105
10,363,552
10%
Export
680,441
602,875
13%
CoGS
7,510,737
6,639,710
13%
Gross Profit
4,546,809
4,326,717
5%
Selling and Dist: Expenses
1,844,256
1,631,905
13%
Admin: Expenses
208,714
210,745
-1%
Other charges
275,557
213,334
29%
Other income
231,007
221,848
4%
Finance cost
4,667
2,621
78%
Profit before Taxation
2,444,622
2,489,960
-2%
Taxation
766,656
789,138
-3%
Net PAT
1,677,966
1,700,822
-1%
EPS – Basic and diluted
17.14
17.37
-1%
Company release on Earnings Report can be accessed here.
